Media Posts
OUR PROGRESS IN APRIL 2026
October 12, 2026
WP8 Development of Network Activities
Welcome to the April 2026 edition of the EUnetCCCWP8 newsletter!
April was a month of implementation and outreach across WP8. From the Guidelines Exchange Program closing its first call to teams presenting EUnetCCC at international venues such as OHDSI Europe and preparing for IARC 60, several tasks moved from designing frameworks to running concrete activities. Research nurses, prevention hubs and survivorship tools all gained momentum, with practical implementation taking centre stage.
Read on for the latest updates from across WP8.
Task 8.2.1 Guidelines
Launch of the Guidelines Exchange Program andcore group meeting in Porto
Guidelines Exchange Program: Applications to the EUnetCCC Guidelines ExchangeProgram closed in April. We are very pleased with the broad and diverse range ofComprehensive Cancer Centres (CCCs) that applied. Submissions are now under reviewand applicant institutions will be contacted shortly with next steps for collaboration. Theprogramme aims to foster shared learning, promote best practices and strengthencollaboration across the European network of CCCs.
Core group meeting and Patient Involvement Workshop in Porto: On 22-23 April, theEUnetCCC Core Group Guidelines met at IPO Porto for two days of intensive andproductive work. Day 1 focused on core guideline activities, including outreach to medicalsocieties, work on quality indicators and engagement with CCCs within EUnetCCC, aswell as structured discussions on the framework of the Guidelines Exchange Program.
Day 2 was dedicated to a workshop on patient involvement, organised with GuidelinesWork Group 5, focused on establishing contacts with patient organisations and advocacygroups. Contributions from Delia Nicoara and a patient perspective highlighted theimportance of clinical guidelines from a patient point of view and presented ongoingpatient collaboration activities within WP8. Overall, the two days provided a strongfoundation for continued core team work and clear next steps across the working groups.

Task 8.2.2 Personalized Cancer Prevention
Cancer Prevention Hubs: from theory to practice
At the latest Prevention Core meeting, Task 8.2.2 partners focused on advancing theimplementation of Cancer Prevention Hubs within Comprehensive Cancer Centres(CCCs). The discussion highlighted the shift from theory to practice, with new CRANE-based checklists and patient-oriented materials being developed to support risk factormanagement, including tobacco use and hereditary cancer.
Work continues to align these efforts with the European Code Against Cancer (ECAC),supported by a Delphi-based implementation approach. Key questions remain around howPrevention Hubs should function in practice (physical or hybrid models) and how to ensurestrong organisational commitment across centres.
This work will be showcased at the IARC 60 conference through a dedicated poster on theCancer Prevention Hub framework. Next steps include finalising practical tools,contributing to a joint scientific article and continuing partner engagement.

Task 8.2.5 Secondary Use of Clinical Data
Collaboration and alignment at OHDSI Europe inRotterdam
Task 8.2.5 participated in the OHDSI Europe Workshop and Symposium in Rotterdam on18-20 April, where the team was invited to present EUnetCCC and our plans for multi-institutional collaborative RWE oncology protocols in OMOP CDM across EuropeanComprehensive Cancer Centres.
The initial protocol concept was well received. The Workshop and Symposium proved tobe an excellent setting for networking with experts in OMOP CDM, data managers andclinicians interested in RWE from European hospitals, as well as representatives fromrelated Joint Actions working towards implementation of the OMOP common data model.

Task 8.2.6 Clinical Trials
Insights from the first Research Nurses thematicexpert meeting
On 22 April 2026, the Clinical Trials Task hosted an online thematic expert meeting as partof its series on Research Nurses in Clinical Trials, bringing together around 120participants from across the clinical trial landscape. The session, titled "a day or a week inthe life of a research nurse", featured expert contributions from Elisa Koskelainen (HelsinkiUniversity Hospital Comprehensive Cancer Center, Finland), Judy Lehr (HannoverMedical School, Germany), Loukia Georgiou (Bank of Cyprus Oncology Centre, Cyprus)and Tjaša Korošec (Institute of Oncology Ljubljana, Slovenia), and was moderated byLaura Bascuñana (Vall d'Hebron Institute of Oncology, Spain).
Experts highlighted the diverse yet essential roles of research nurses in patient care,study coordination, data quality, regulatory compliance and cross-departmentalcollaboration, as well as their critical contribution to patient safety and high-quality trialdelivery. Discussions also emphasised the importance of clear team structures and strongcollaboration, linking well-defined roles to job satisfaction, staff retention and sustainableresearch nursing careers. Examples from different centres illustrated how research nursescontribute to innovation and process improvements, supporting more efficient clinical trialconduct.
The next session, on 10 June 2026, will focus on research nurses in Phase I trials and theeducational aspects of transitioning from clinical to research nursing. Invitations will becirculated soon.
Task 8.2.7 Cancer Survivorship
Strengthening survivorship implementation acrossCCCs
Recent discussions within Task 8.2.7 focused on accelerating the transition from planningto practical implementation across Comprehensive Cancer Centres (CCCs). A key priorityis the development of screening tools and an implementation framework, which will serveas the foundation for future Survivorship Hub pilots. Partners agreed that these tools mustbe finalised before moving into pilot testing, ensuring a structured and scalable approach.
Strong emphasis was placed on coordination across thematic working groups to avoidduplication and ensure alignment, particularly in areas such as patient navigation, physicalactivity, nutrition and addiction support. In parallel, the Survivorship Hub model continuesto evolve as a modular and adaptable framework, designed to fit different institutionalcapacities and patient needs while maintaining a patient-centred approach across theentire care pathway.
The upcoming Brussels teaming meeting on 17-18 September will play a key role inconsolidating screening tools, aligning deliverables and advancing implementationplanning across centres.
Task 8.3 Dissemination & Evaluation
Aligning Task 8.1 and Task 8.3 in Stockholm
The Task 8.1 and Task 8.3 teams are preparing for a joint face-to-face working meeting inStockholm. The two days will focus on aligning operations between infrastructure (Task8.1) and dissemination (Task 8.3), so that the support offered to the 8.2 tasks is morecoordinated, responsive and visible.
Discussions will cover how shared activities, tools and communication flows can betterserve task leads and partners across the network, with a particular focus on streamliningrequests, updates and outputs through the WP8 central hub.
Detailed outcomes will be shared in the next newsletter.
UPCOMING EVENTS
May 19-21, 2026Task 8.2.2 | Personalized Cancer Prevention
IARC 60 conference
Task 8.2.2 will showcase its work through a dedicatedposter on the Cancer Prevention Hub framework at theIARC 60 conference.
Lyon, France
May 21-22, 2026Task 8.2.6 | Clinical Trials
Core group meeting: ClinicalTrials task
Second in-person meeting of the Clinical Trials task. Fullday on 21 May, half day on 22 May. Agenda underdevelopment.
North Estonia Medical Centre, Tallinn
May 28-29, 2026Task 8.2.3 | Cancer Research
Cancer research face-to-faceworkshop
Topics include biobanking and biomarkers, small-scaleresearch collaborations, patient involvement, de-escalation studies and an educational course for studynurses and investigators.
Helsinki University Hospital, Finland
September 17-18, 2026Task 8.2.7 | Cancer Survivorship
Survivorship teaming activity
Interactive meeting bringing partners together to alignon screening tools, implementation frameworks andnext steps for Survivorship Hubs, with a strong focus onpractical implementation across CCCs. More details andregistration will follow.
Brussels, Belgium
MISSED THE PREVIOUS 2026 EDITIONS? CHECK THEM HERE:
Read the January Newsletter
Read the February Newsletter
Read the March Newsletter